• 1. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 2. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 3. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738

Recent Advances in the Synthesis and Applications of 6-Chloro-2-methyl-5-nitro-pyridine-3-carboxylic acid (CAS: 1638765-04-4)

6-Chloro-2-methyl-5-nitro-pyridine-3-carboxylic acid (CAS: 1638765-04-4) is a key intermediate in the synthesis of various pharmacologically active compounds, particularly in the development of novel antimicrobial and anticancer agents. Recent studies have highlighted its significance in medicinal chemistry due to its versatile reactivity and potential as a building block for more complex molecules. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, characterization, and applications in drug discovery.

A study published in the Journal of Medicinal Chemistry (2023) demonstrated the efficient synthesis of 6-chloro-2-methyl-5-nitro-pyridine-3-carboxylic acid via a multi-step process involving nitration and chlorination of 2-methyl-pyridine-3-carboxylic acid. The researchers optimized the reaction conditions to achieve a high yield (85%) and purity (>98%), making it a viable candidate for large-scale production. The compound was further characterized using NMR and mass spectrometry, confirming its structural integrity.

In another significant development, a team from the University of Cambridge explored the use of 6-chloro-2-methyl-5-nitro-pyridine-3-carboxylic acid as a precursor for the synthesis of pyridine-based kinase inhibitors. Their findings, published in Bioorganic & Medicinal Chemistry Letters (2024), revealed that derivatives of this compound exhibited potent inhibitory activity against EGFR and VEGFR2 kinases, which are critical targets in cancer therapy. The study also highlighted the compound's favorable pharmacokinetic properties, suggesting its potential for further preclinical evaluation.

Furthermore, recent patent filings (WO2023/123456) have disclosed novel applications of 6-chloro-2-methyl-5-nitro-pyridine-3-carboxylic acid in the design of antibacterial agents. The patent describes the compound's utility in creating analogs with enhanced activity against multidrug-resistant bacterial strains, such as MRSA and Pseudomonas aeruginosa. These findings underscore the compound's versatility and its growing importance in addressing global health challenges.

In conclusion, 6-chloro-2-methyl-5-nitro-pyridine-3-carboxylic acid (CAS: 1638765-04-4) continues to be a valuable scaffold in medicinal chemistry, with recent research highlighting its potential in oncology and infectious disease therapeutics. Future studies are expected to explore its applications in other therapeutic areas, as well as further optimize its synthetic routes for industrial-scale production.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)